newsfilter
← Latest News
GlobeNewswire·

Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates

Ocaliva® (obeticholic acid or OCA) net sales of $83.7 million, representing 17% growth over the prior year quarterCompany updates full-year 2023 Ocaliva net sales guidance to $320 million to $340 million; reiterates